• Myasthenic syndrome secondary to small cell lung cancer has been studied In five patients who achieved complete remission with chemotherapy. The relationship between response or relapse of the neoplasm to therapy and the activity of the myasthenic syndrome is variable. This inconsistent clinical correlation between the cancer and its paraneoplastic syndrome is examined in view of current data on the immunologic basis of myasthenic syndrome.
(Arch Intern Med 1984;144:999-1000)
Clamon GH, Evans WK, Shepherd FA, Humphrey JG. Myasthenic Syndrome and Small Cell Cancer of the Lung: Variable Response to Antineoplastic Therapy. Arch Intern Med. 1984;144(5):999–1000. doi:10.1001/archinte.1984.00350170157026
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: